Exsilio Therapeutics launched on Wednesday with an $82 million series A fundraising round co-led by Novartis Venture Fund and Delos Capital. The company’s interim CEO, Tal Zaks, says that while ...
In his new book, “The Catalyst,” Dr. Thomas Cech describes how mRNA in the COVID vaccines encodes the virus’s spike protein. The following is an excerpt from The Catalyst: RNA and the Quest to Unlock ...
DURING THE covid-19 pandemic new vaccines were rolled out with unprecedented speed. The fastest to arrive were jabs built from molecules of messenger RNA (mRNA) designed to teach the body how to fight ...
SHANGHAI/SUZHOU, China, April 19 (Reuters) - China's vaccine developers stuck with unused mRNA COVID shots and idle manufacturing plants are pursuing new targets for the novel messenger RNA technology ...
Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. AbbVie is entering a collaboration and license option deal ...
Kaiser Permanente was hit by a data breach in mid-April, impacting 13.4 million health plan members; GlaxoSmithKline (GSK) sued Pfizer and BioNTech for allegedly infringing on its messenger RNA ...
- Collaboration to leverage AbbVie's expertise in biotherapeutic drug development and commercialization together with ADARx's proprietary RNA technology to advance next-generation siRNA therapies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback